Cargando…
Searching for Biomarkers in the Blood of Patients at Risk of Developing Parkinson’s Disease at the Prodromal Stage
Parkinson’s disease (PD) is diagnosed many years after its onset, under a significant degradation of the nigrostriatal dopaminergic system, responsible for the regulation of motor function. This explains the low effectiveness of the treatment of patients. Therefore, one of the highest priorities in...
Autores principales: | Katunina, Elena A., Blokhin, Victor, Nodel, Marina R., Pavlova, Ekaterina N., Kalinkin, Alexander L., Kucheryanu, Valerian G., Alekperova, Leyla, Selikhova, Marianna V., Martynov, Mikhail Yu., Ugrumov, Michael V. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9915927/ https://www.ncbi.nlm.nih.gov/pubmed/36768161 http://dx.doi.org/10.3390/ijms24031842 |
Ejemplares similares
-
Changes in Tyrosine Hydroxylase Activity and Dopamine Synthesis in the Nigrostriatal System of Mice in an Acute Model of Parkinson’s Disease as a Manifestation of Neurodegeneration and Neuroplasticity
por: Kolacheva, Anna, et al.
Publicado: (2022) -
A Pilot Study of Changes in the Level of Catecholamines and the Activity of α-2-Macroglobulin in the Tear Fluid of Patients with Parkinson’s Disease and Parkinsonian Mice
por: Bogdanov, Vsevolod, et al.
Publicado: (2021) -
Compensatory Processes in Striatal Neurons Expressing the Tyrosine Hydroxylase Gene in Transgenic Mice in a Model of Parkinson’s Disease
por: Troshev, Dmitry, et al.
Publicado: (2023) -
A Monoiodotyrosine Challenge Test in a Parkinson’s Disease Model
por: Kim, A. R., et al.
Publicado: (2021) -
The Sphingolipid Asset Is Altered in the Nigrostriatal System of Mice Models of Parkinson’s Disease
por: Blokhin, Victor, et al.
Publicado: (2022)